Home -> Law Blog Directory -> Intellectual Property Law Blogs -> TinytechIP
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: TinytechIPUS Patent 7453081 - Phase change memory cell including nanocomposite insulator
This patent from Qimonda North America Corp. teaches a variation of phase change memory which incorporates insulating nanoparticles to lower the power required to change bit states. Claim 1 reads:
1. A memory cell comprising:
a first electrode;
a second electrode;
a storage material positioned between the first electrode and the second electrode; and
a nanocomposite insulator contacting the storage material;
wherein the nanocomposite insulator comprises a first material comprising a phase change material and a nano-scaled material comprising insulating nanoparticles distributed within a portion of the first material.
Full post as published by TinytechIP on November 23, 2008 (boomark / email).
Cell Phone Early Termination Fees
How to recover billing errors
New Study Links Cell Phone Radiation to Increased Health Risks
Cell Phone Radiation Is Your Phone Toxic?
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Composix Kugel Mesh Patches
alleging the memory recoil ring has the potential to break and cause bowel perforation or chronic enteric fistulae.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
FDA
Requests Labeling Change for Singulair, Accolate and Zyflo and Zyflo CR
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.

Patent Profile: StemCells Announces Issuance of Human Neural Stem Cell Patent
Netherlands to Phase-out Six-year Patent
StemCellPatents.com Launches New Stem Cell Patent Database
Law Firm Launches Fuel Cell Patent Site
Patent Profile: Immunomedics Announces Issuance of Patent for anti-CD20 Antibody







